Your browser doesn't support javascript.
loading
Fluorescent intracellular imaging of reactive oxygen species and pH levels moderated by a hydrogenase mimic in living cells.
Hu, Xin-Yuan; Li, Jia-Jing; Yang, Zi-Wei; Zhang, Jun; Wang, Huai-Song.
Afiliación
  • Hu XY; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 210009, China.
  • Li JJ; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 210009, China.
  • Yang ZW; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 210009, China.
  • Zhang J; College of Food Science and Bioengineering, Tianjin Agricultural University, Tianjin, 300392, China.
  • Wang HS; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 210009, China.
J Pharm Anal ; 12(5): 801-807, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36320605
ABSTRACT
The catalytic generation of H2 in living cells provides a method for antioxidant therapy. In this study, an [FeFe]-hydrogenase mimic [Ru + Fe2S2@F127(80)] was synthesized by self-assembling polymeric pluronic F-127, catalytic [Fe2S2] sites, and photosensitizer Ru(bpy)3 2+. Under blue light irradiation, hydrated protons were photochemically reduced to H2, which increased the local pH in living cells (HeLa cells). The generated H2 was subsequently used as an antioxidant to decrease reactive oxygen species (ROS) levels in living cells (HEK 293T, HepG2, MCF-7, and HeLa cells). Our findings revealed that the proliferation of HEK 293T cells increased by a factor of about six times, relative to that of other cells (HepG2, MCF-7, and HeLa cells). Intracellular ROS and pH levels were then monitored using fluorescent cell imaging. Our study showed that cell imaging can be used to evaluate the ability of Ru + Fe2S2@F127 to eliminate oxidative stress and prevent ROS-related diseases.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Pharm Anal Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: J Pharm Anal Año: 2022 Tipo del documento: Article País de afiliación: China